Zurich Cantonal Bank’s Onconetix ONCO Stock Holding History

Zurich Cantonal Bank’s Portfolio ONCO Stock Details ONCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$1.17K	–	2613
2025 Q1	$1.17K	Sell	4 -45	-92%	-$77.2K	﹤0.01%	2614
2024 Q4	$131K	Sell	49 -83	-63%	-$840K	﹤0.01%	2336
2024 Q3	$2.93M	Buy	132 +130	+6,500%	+$3.12M	0.01%	700
2024 Q2	$51.2K	Buy	+2	New	+$50.8K	﹤0.01%	2535

Other funds holding ONCO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Zurich Cantonal Bank's ONCO Position: Q2 2025 in Review

Zurich Cantonal Bank sold out of Onconetix (ONCO) in Q2 2025, closing a stake of 4 shares — an estimated $1.17K sold.

Zurich Cantonal Bank first reported a position in ONCO in Q2 2024 and held it in 4 quarters. The position peaked at $2.93M in Q3 2024. 5 funds tracked by Wall St. Rank hold ONCO as of Q2 2025.

Zurich Cantonal Bank reported no remaining Onconetix position as of Q2 2025 after selling out during the quarter.
Zurich Cantonal Bank sold 4 Onconetix shares in Q2 2025, an estimated $1.17K.
Zurich Cantonal Bank first reported a position in Onconetix in Q2 2024 and held it in 4 quarters.
Zurich Cantonal Bank's Onconetix position peaked at $2.93M in Q3 2024.
5 funds tracked by Wall St. Rank held Onconetix as of Q2 2025.

Based on Zurich Cantonal Bank's 13F filing for Q2 2025, filed 7 Aug 2025.